NanoARG: a web service for detecting and contextualizing antimicrobial resistance genes from nanopore-derived metagenomes
Gustavo Arango-Argoty(AstraZeneca (South Korea)), Lijun Zhang(Dalian Medical University), Amy Pruden(Vanda Institute), Lenwood S. Heath(Virginia Tech), Peter J. Vikesland(Virginia Tech), Dongjuan Dai(Virginia Tech)
Cited by 119
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
DeepARG: a deep learning approach for predicting antibiotic resistance genes from metagenomic data
|Microbiome|2018|962
FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer
|Clinical Cancer Research|2014|350
First FDA Approval of Neoadjuvant Therapy for Breast Cancer: Pertuzumab for the Treatment of Patients with HER2-Positive Breast Cancer
|Clinical Cancer Research|2014|153
An in-depth map of polyadenylation sites in cancer
|Nucleic Acids Research|2012|151